Mechanisms of therapeutic resistance in ER plus breast cancer

被引：0
|
作者：
Clarke, R. B. [1 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Metastatic ER plus Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches
    Raheem, Farah
    Karikalan, Suganya Arunachalam
    Batalini, Felipe
    El Masry, Aya
    Mina, Lida
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [2] Mechanisms of succinate-mediated drug resistance in ER plus breast cancer
    Hogstrom, Jenny
    Petrova, Boryana
    Perea, Camila
    Ward, Madelyn
    Wulf, Gerburg
    Collins, Laura
    Kanarek, Naama
    Muranen, Taru
    CANCER RESEARCH, 2024, 84 (06)
  • [3] RSK as a Therapeutic Target for ER plus Breast Cancer
    Faltas, Christina
    Holz, Marina K.
    FASEB JOURNAL, 2022, 36
  • [4] Mechanisms of resistance to CDK4/6 inhibition in ER plus breast cancer
    Lee, N. V.
    Eisele, K. J.
    Chionis, J.
    Yuan, J.
    Zhu, Z.
    Liu, C.
    Li, D.
    Olson, P. A.
    Fantin, V.
    Arndt, K. T.
    Shields, D. J.
    VanArsdale, T. L.
    CANCER RESEARCH, 2016, 76
  • [5] Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER plus ) breast cancer
    Toska, Eneda
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [6] Network-based inference of resistance mechanisms to estrogen inhibitors in ER plus breast cancer
    Alvarez, Mariano Javier
    Shen, Yao
    Bisikirska, Brygida
    Realubit, Ronald
    Pampou, Sergey
    Karan, Charles
    Califano, Andrea
    CLINICAL CANCER RESEARCH, 2015, 21
  • [7] Therapeutic Potential for Targeting Autophagy in ER plus Breast Cancer
    Finnegan, Ryan M.
    Elshazly, Ahmed M.
    Schoenlein, Patricia, V
    Gewirtz, David A.
    CANCERS, 2022, 14 (17)
  • [8] Hormonal regulation of SEMA7A promotes therapeutic resistance in ER plus breast cancer.
    Crump, Lyndsey S.
    Wyatt, Garhett L.
    Rutherford, Taylor R.
    Richer, Jennifer K.
    Porter, Weston W.
    Lyons, Traci R.
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Unveiling mechanisms of CDK4/6 inhibitor resistance in ER plus breast cancer models with acquired resistance
    Li, Bin
    Liu, Gaoxiang
    Ni, Ting
    Shi, Wenting
    Gu, Qingyang
    CANCER RESEARCH, 2024, 84 (06)
  • [10] The therapeutic capability of amino acid uptake in ER plus breast cancer
    Saito, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 158 - 158
12345